Lynch Asset Management, Inc. NVO Holdings History
Lynch Asset Management, Inc.'s Novo Nordisk AS Holding Summary
As of 2025-03-31, Lynch Asset Management, Inc. held 108,100.00 shares of Novo Nordisk AS(NVO), totaling $7.51 Mil. This investment constitutes 3.37% of their stock portfolio, and Lynch Asset Management, Inc. now holds 0% of the outstanding Novo Nordisk AS(NVO) stock.
The initial trade took place in 2021Q4. And since then Lynch Asset Management, Inc. has made 3 purchases of NVO, at an average price of $55.96, for a total of 110,100.00 shares. In addition, there have been 1 sales at an average price of $132.51 for 2,000.00 shares. Based on historical transaction data and NVO's current price of $70.73, Lynch Asset Management, Inc.'s estimated gain on his NVO holdings is $1.75 Mil, reflecting a 28.40% gain to date.
Lynch Asset Management, Inc. NVO ($70.73) Holding Chart
Lynch Asset Management, Inc. NVO ($70.73) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
